▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

First Ascent Biomedical Secures $6 Million Investment from Vidal Duart Enterprises, Inc. to Revolutionize Cancer Treatment

First Ascent Biomedical, a pioneer in personalized cancer treatment, today announced a $6 million investment from Vidal Duart Enterprises, Inc., with an additional co-investment from Techstars. The fu...

Business Wire

The company will use the funding to open its first commercial lab in Florida

MIAMI: First Ascent Biomedical, a pioneer in personalized cancer treatment, today announced a $6 million investment from Vidal Duart Enterprises, Inc., with an additional co-investment from Techstars. The funding will accelerate First Ascent Biomedical’s mission to transform medical oncology with highly individualized, prospective treatment planning technologies that improve patient survival.

First Ascent Biomedical’s technology represents a shift from a one-size-fits-all approach to a tailored strategy, offering hope to cancer patients who have exhausted traditional options. The company’s functional precision medicine platform integrates drug testing, DNA/RNA sequencing and AI-guided tumor weakness mapping to test hundreds of FDA-approved drugs against a patient's unique cancer profile. The platform delivers a highly personalized, actionable plan to a patient’s physician in an average of 10 days. Results show that First Ascent Biomedical’s technology has significantly improved patient outcomes. Patients treated with decisions guided by the platform demonstrated an 83% greater benefit than those treated with the standard of care of a doctor’s choice.

The platform’s technology was developed by Dr. Noah Berlow, co-founder and CTO, and Dr. Diana Azzam, First Ascent Biomedical’s co-founder and scientific advisor. Dr. Berlow designed the company’s AI framework. Dr. Azzan brings years of cancer research and a wealth of functional precision medicine expertise to First Ascent Biomedical, currently serving as an assistant professor of environmental health sciences at the Florida International University Robert Stempel College of Public Health and Social Work.

The capital raised will support the expansion of First Ascent Biomedical’s operations, including the establishment of a state-of-the-art lab in Florida, where the company will continue its mission to transform cancer care for all patients, especially those in underserved communities.

“The funding we have raised is a defining moment for First Ascent Biomedical and for cancer care,” said Jim Foote, Co-founder and CEO of First Ascent Biomedical. “As someone who tragically lost my son to cancer, I know the devastating toll this disease takes on families. With this fresh capital, we are not just advancing technology—we are giving patients and their families hope. Florida is where our technology was invented, so we are excited to open our first commercial lab here as we charge forward in making personalized cancer care widely accessible.”

“First Ascent Biomedical is at the forefront of a new era in cancer treatment. Their groundbreaking technology has already proven its potential to save lives and change the trajectory of this disease,” said Carlos Duart, Owner of Vidal Duart Enterprises. “This investment is not just a business decision—it’s a commitment to improving outcomes for cancer patients everywhere.”

Tina Vidal Duart, Co-owner of Vidal Duart Enterprises, added: “We are proud to support a company that combines innovation with compassion. The work First Ascent Biomedical is doing will have a ripple effect far beyond Florida, giving patients personalized care that improves their chances of survival. We are honored to help bring this vision to life.”

“First Ascent Biomedical represents the future of cancer care, where innovation and personalization come together to save lives,” said Andrew Cleland, Chief Investment Officer at Techstars. “The opportunity to transform medical oncology through precision medicine is immense, and First Ascent Biomedical is paving the way to make customized cancer treatment a reality with its drug prediction technologies.”

About First Ascent Biomedical

First Ascent Biomedical is a leader in Functional Precision Medicine, leveraging advanced technologies to personalize cancer treatment. With roots in Florida and a commitment to improving patient outcomes, the company’s platform has been shown to significantly outperform standard care, offering a new frontier in oncology.

About Vidal Duart Enterprises, Inc.

Vidal Duart Enterprises is a private investment firm dedicated to empowering transformative ventures. Led by Carlos and Tina Vidal Duart, the firm focuses on supporting groundbreaking innovations that create lasting social and economic impact.

About Techstars

Techstars helps founders succeed. Through our global accelerators, we invest in early-stage startups led by founders building a better future for everyone. We leverage our vast network of alumni, mentors, partners and investors to support entrepreneurs and build thriving startup communities. Since 2006, we have invested in industry-defining companies including Chainalysis, Zipline, DataRobot, Alloy and many, many more. www.techstars.com

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

CoStar Group Acquires Ag-Analytics, Augmenting Land.com Services and Capabilities

CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group,” “we” or “our”), a leading provider of online real estate marketplaces, information and analytics in…

BJ’s Wholesale Club to Open in Brooksville, Florida, on February 21

BJ’s Wholesale Club (NYSE: BJ) announced today that its club in Brooksville, Florida, will open on February 21, 2025. The club, located at 13085 Cortez…

University of Phoenix College of Doctoral Studies Releases White Paper…

University of Phoenix College of Doctoral Studies has released a new white paper, “Economic Influence of AI on Career Optimism,” by Christine Marquis,…

Qurate Retail, Inc. Declares Quarterly Cash Dividend on 8.0% Series A…

Qurate Retail, Inc. (Nasdaq: QRTEA, QRTEB, QRTEP) today announced that an authorized committee of its Board of Directors declared the regular quarterly…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!